Health IT

A former Navy SEAL's tech startup marks one year of using AI to help veterans navigate the VA claims maze for free, taking on predatory firms and red tape.

A new partnership between Southern Research and Pathogenus Consulting combines US labs with a European network to fast-track treatments for global health threats.

The EpiFaith® Smart Syringe secures landmark deals with the UK's NHS and Paris's AP-HP, signaling a new era for patient safety and market access.

After flawless human trials, a Chapel Hill startup secures funding to bring its revolutionary ultrasound-based blood clot treatment to the United States.

After a four-year campaign, the World Health Organization is poised to recognize a silent liver epidemic, setting the stage for a new global NCD strategy.

New online communities offer an 'emotional prescription' for patients, but can the platform's 'gold standard' model balance support with business?

As fraudulent hospice claims top $3 billion, a new private certification program hopes to restore trust and protect vulnerable end-of-life patients.

With new CTO Sharath Pasupunuti, Sidecar Health doubles down on its AI strategy to empower consumers and challenge the traditional health insurance model.

A new brand claims its decadent milkshakes improve gut health and mood, using invisible science to challenge the war between pleasure and well-being.

Precision medicine firm Atropos Health joins NY's elite digital health startups, signaling a market shift toward scalable, data-driven healthcare solutions.

As millions face losing healthcare, AI startup Graici has secured $7.5M to automate Medicaid renewals, betting its data wallet can solve a national crisis.

January data shows stable job and wage growth for U.S. small businesses, yet persistent labor shortages and rising healthcare costs paint a complex picture.

Planet DDS's new AI voice tool promises consistency for DSOs, but in a crowded market, will its integrated approach redefine workflows and patient care?

A major multi-vendor study confirms AI's power for precision HER2 scoring, promising to improve diagnostics and accelerate personalized cancer therapies.

A bipartisan bill in Congress aims to give veterans access to emerging mental health treatments, including the novel, non-hallucinogenic compound MEAI.

A new FDA-approved device offers a drug-free alternative for severe rheumatoid arthritis. Rush University is the first in Chicago to implant the system.

With a key drug for a rare disease nearing the finish line, Spruce adds two industry veterans to navigate the high-stakes FDA approval process.

A new data-driven wellness program in Ontario is dramatically reducing cancer risk for firefighters, offering a blueprint for saving lives and city funds.

Estrella Immunopharma unveils promising Phase 1 data for its next-gen T-cell therapy, but can it overcome a crowded market and its own financial hurdles?

New multi-year data for Fabry and Pompe disease therapies from Amicus Therapeutics showcases sustained benefits, offering new hope for long-term patient outcomes.